• Medientyp: E-Artikel
  • Titel: The Neutral Glycosphingolipid Globotriaosylceramide Promotes Fusion Mediated by a CD4-Dependent CXCR4-Utilizing HIV Type 1 Envelope Glycoprotein
  • Beteiligte: Puri, Anu; Hug, Peter; Jernigan, Kristine; Barchi, Joseph; Kim, Hee-Yong; Hamilton, Jillon; Wiels, Joelle; Murray, Gary J.; Brady, Roscoe O.; Blumenthal, Robert
  • Erschienen: National Academy of Sciences of the United States of America, 1998
  • Erschienen in: Proceedings of the National Academy of Sciences of the United States of America, 95 (1998) 24, Seite 14435-14440
  • Sprache: Englisch
  • ISSN: 0027-8424
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: Previously, we showed that the addition of human erythrocyte glycosphingolipids (GSLs) to nonhuman CD4+or GSL-depleted human CD4+cells rendered those cells susceptible to HIV-1 envelope glycoprotein-mediated cell fusion. Individual components in the GSL mixture were isolated by fractionation on a silica-gel column and incorporated into the membranes of CD4+cells. GSL-supplemented target cells were then examined for their ability to fuse with TF228 cells expressing HIV-1LAIenvelope glycoprotein. We found that one GSL fraction, fraction 3, exhibited the highest recovery of fusion after incorporation into CD4+nonhuman and GSL-depleted HeLa-CD4 cells and that fraction 3 contained a single GSL fraction. Fraction 3 was characterized by MS, NMR spectroscopy, enzymatic analysis, and immunostaining with an antiglobotriaosylceramide (Gb3) antibody and was found to be Gal(α 1→ 4)Gal(β 1→ 4)Glc-Cer (Gb3). The addition of fraction 3 or Gb3 to GSL-depleted HeLa-CD4 cells recovered fusion, but the addition of galactosylceramide, glucosylceramide, the monosialoganglioside, GM3, lactosylceramide, globoside, the disialoganglioside, GD3, or α -galactosidase A-digested fraction 3 had no effect. Our findings show that the neutral GSL, Gb3, is required for CD4/CXCR4-dependent HIV-1 fusion.
  • Zugangsstatus: Freier Zugang